105 related articles for article (PubMed ID: 6135172)
1. Influence of streptozotocin-induced diabetes on growth hormone secretion in the rat.
Bluet-Pajot MT; Durand D; Kordon C
Neuroendocrinology; 1983; 36(4):307-9. PubMed ID: 6135172
[TBL] [Abstract][Full Text] [Related]
2. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
[TBL] [Abstract][Full Text] [Related]
3. Effect of streptozotocin diabetes and insulin replacement on growth hormone in rats.
Gonzalez C; Jolin T
J Endocrinol Invest; 1985 Feb; 8(1):7-11. PubMed ID: 3886772
[TBL] [Abstract][Full Text] [Related]
4. Impaired suppression of growth hormone release by somatostatin in cultured adenohypophyseal cells of spontaneously diabetic BB/W rats.
Welsh JB; Szabo M
Endocrinology; 1988 Nov; 123(5):2230-4. PubMed ID: 2901949
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic regulation of impaired growth hormone secretion in diabetic rats. 1. Studies in streptozotocin-induced diabetic rats.
Ndon JA; Giustina A; Wehrenberg WB
Neuroendocrinology; 1992 May; 55(5):500-5. PubMed ID: 1350066
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic secretion of somatostatin and growth hormone-releasing factor into the hypophysial-portal circulation is reduced in streptozotocin diabetic male rats.
Plotsky PM
Neuroendocrinology; 1991 May; 53(5):433-8. PubMed ID: 1678493
[TBL] [Abstract][Full Text] [Related]
7. Thyroidectomy abolishes pulsatile growth hormone secretion without affecting hypothalamic somatostatin.
Martin D; Epelbaum J; Bluet-Pajot MT; Prelot M; Kordon C; Durand D
Neuroendocrinology; 1985 Dec; 41(6):476-81. PubMed ID: 2867482
[TBL] [Abstract][Full Text] [Related]
8. Suppression of episodic growth hormone secretion in streptozotocin-induced diabetic mice: time-course studies on the hypothalamic pituitary axis.
Murao S; Sato M; Tamaki M; Niimi M; Ishida T; Takahara J
Endocrinology; 1995 Oct; 136(10):4498-504. PubMed ID: 7664670
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone.
Tannenbaum GS; Painson JC; Lengyel AM; Brazeau P
Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683
[TBL] [Abstract][Full Text] [Related]
10. Diurnal variations of plasma growth hormone, thyrotropin, thyroxine, and triiodothyronine in streptozotocin-diabetic and food-restricted rats.
Ortiz-Caro J; González C; Jolin T
Endocrinology; 1984 Dec; 115(6):2227-32. PubMed ID: 6238818
[TBL] [Abstract][Full Text] [Related]
11. Development of hypothalamic control of growth hormone secretion in the rat.
Khorram O; DePalatis LR; McCann SM
Endocrinology; 1983 Aug; 113(2):720-8. PubMed ID: 6135598
[TBL] [Abstract][Full Text] [Related]
12. Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat.
Bruno JF; Xu Y; Song J; Berelowitz M
Endocrinology; 1994 Nov; 135(5):1787-92. PubMed ID: 7956902
[TBL] [Abstract][Full Text] [Related]
13. Effect of growth hormone-releasing stimuli in streptozotocin diabetic rats.
Locatelli V; Miyoshi H; Bestetti G; Rossi GL; Müller EE
Brain Res; 1985 Aug; 341(1):35-40. PubMed ID: 2931155
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin rapidly restores rat growth hormone (GH) release response attenuated by prior exposure to human GH-releasing factor in vitro.
Soya H; Suzuki M
Endocrinology; 1988 Jun; 122(6):2492-8. PubMed ID: 2897284
[TBL] [Abstract][Full Text] [Related]
15. The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3',5'-monophosphate-stimulated GH release from rat pituitary cells in monolayer culture.
Cuttler L; Welsh JB; Szabo M
Endocrinology; 1986 Jul; 119(1):152-8. PubMed ID: 2873023
[TBL] [Abstract][Full Text] [Related]
16. Decreased hypothalamic growth hormone-releasing hormone content and pituitary responsiveness in hypothyroidism.
Katakami H; Downs TR; Frohman LA
J Clin Invest; 1986 May; 77(5):1704-11. PubMed ID: 2871046
[TBL] [Abstract][Full Text] [Related]
17. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
Soya H; Suzuki M
Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
[TBL] [Abstract][Full Text] [Related]
18. Effect of withdrawal of somatostatin and growth hormone (GH)-releasing factor on GH release in vitro.
Kraicer J; Sheppard MS; Luke J; Lussier B; Moor BC; Cowan JS
Endocrinology; 1988 May; 122(5):1810-5. PubMed ID: 2896117
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
Park S; Peng XD; Frohman LA; Kineman RD
Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
[TBL] [Abstract][Full Text] [Related]
20. Presence of an adenylate cyclase dually regulated by somatostatin and human pancreatic growth hormone (GH)-releasing factor in GH-secreting cells.
Spada A; Vallar L; Giannattasio G
Endocrinology; 1984 Sep; 115(3):1203-9. PubMed ID: 6146515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
